Delivery Order SPE2DB24D2011-SPE2DB24FBPFH
Award Date 4/4/24
Potential Completion Date 4/5/24
Potential Value $10K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,103.58 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The contract has a completion date of February 21, 2024 and was awarded on February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $5,102.97, is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Ozempic 0.25-0.5 mg/dose pens. This $2,004.62 contract has an ultimate completion date of April 4, 2024. AmerisourceBergen Drug Corp, a for-profit organization based in Conshohocken, Pennsylvania, serves as the prime contractor. This delivery order is part of a...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ozempic 0.25-0.5 mg/dose pens. The total potential value of the contract is $5,221.19 with a completion date of February 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside contract. This delivery order is part of a larger indefinite...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $7,399.59 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. This contract has a performance period through March 15, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ozempic 0.25-0.5 mg/dose pens. The contract, valued at $21,433.56, has an ultimate completion date of April 15, 2024 and was awarded on April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The $5,570.89 contract, which has an ultimate completion date of April 8, 2024, does not have a set-aside designation. AmerisourceBergen Drug Corp, the prime contractor, is also the holder of a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to provide a wide...
- The U.S. Defense Logistics Agency (DLA) awarded a $9,859.73 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ozempic 0.25-0.5 mg/dose pens. This delivery order contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. The IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $1,952.72 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products. This contract has an ultimate completion date of August 21, 2024 and is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The order, valued at $3,162.69, is for the supply of Ozempic 0.25-0.5 mg/dose pens to support military treatment programs and facilities. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB24FBPFHDelivery Order
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract, valued at $10,080.39, has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This award is not associated with any set-aside designation.
Generated 7/4/24, 10:23 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 4/4/24 |